Farallon Capital group discloses 8.3% Enanta (ENTA) ownership in Schedule 13G/A
Rhea-AI Filing Summary
Farallon Capital Management, L.L.C. and affiliated funds report beneficial ownership of Enanta Pharmaceuticals, Inc. common stock. The group holds 2,418,202 Shares of Enanta’s common stock, representing 8.3% of the outstanding class, with no sole voting or dispositive power and all authority held on a shared basis.
The shares are held directly by a group of investment partnerships referred to as the Farallon Funds, for which Farallon Capital Management, L.L.C. acts as investment manager. A number of managing and senior managing members of the investment manager are also reporting persons, reflecting their shared voting and investment power over these holdings.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 2,418,202 Shares
Percent of class: 8.3%
Sole voting power: 0
+4 more
7 metrics
Shares beneficially owned
2,418,202 Shares
Common stock of Enanta Pharmaceuticals, Inc.
Percent of class
8.3%
Percentage of Enanta Pharmaceuticals common stock class
Sole voting power
0
Shares over which reporting persons have sole voting power
Shared voting power
2,418,202
Shares over which reporting persons have shared voting power
Sole dispositive power
0
Shares over which reporting persons have sole dispositive power
Shared dispositive power
2,418,202
Shares over which reporting persons have shared dispositive power
Amendment number
8
Amendment No. 8 to Schedule 13G for Enanta Pharmaceuticals
Key Terms
beneficially owned, shared voting power, shared dispositive power, investment manager, +1 more
5 terms
beneficially owned financial
"The Shares reported hereby as beneficially owned by the Reporting Persons are held directly"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
investment manager financial
"the Investment Manager is the investment manager of certain investment partnerships"
Schedule 13G regulatory
"Exhibit 1. Joint Acquisition Statement Pursuant to Section 240.13d-1(k)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
What percentage of ENTA does Farallon Capital report owning?
Farallon Capital and related reporting persons report beneficial ownership of 8.3% of Enanta Pharmaceuticals’ common stock, representing 2,418,202 Shares held through various Farallon investment funds under shared voting and dispositive power.
Who are the reporting persons in this ENTA Schedule 13G/A?
Reporting persons include Farallon Capital Management, L.L.C., multiple Farallon investment funds, and several managing or senior managing members such as Joshua J. Dapice and Hannah E. Dunn, all sharing voting and dispositive power over the reported shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.